SOLIGENIX, INC. Lessee, Operating Lease, Discount Rate
SOLIGENIX, INC. (SNGX) had Lessee, Operating Lease, Discount Rate of 8.47% as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2026-03-31
- 2025-12-31: Lessee, Operating Lease, Discount Rate 8.47%.
- 2024-12-31: Lessee, Operating Lease, Discount Rate 8.47%.
- 2023-12-31: Lessee, Operating Lease, Discount Rate 8.47%.
- 2022-12-31: Lessee, Operating Lease, Discount Rate 8.47%.
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2025-12-31 | 8.47% 10-K · filed 2026-03-31 |
| 2024-12-31 | 8.47% 10-K · filed 2025-03-21 |
| 2023-12-31 | 8.47% 10-K · filed 2024-03-15 |
| 2022-12-31 | 8.47% 10-K · filed 2023-03-31 |
| 2021-12-31 | 10.00% 10-K · filed 2022-03-29 |
| 2020-12-31 | 10.00% 10-K · filed 2021-03-30 |
| 2019-12-31 | 10.00% 10-K · filed 2020-03-30 |
| 2019-09-30 | 10.00% 10-Q · filed 2019-11-12 |
| 2019-06-30 | 10.00% 10-Q · filed 2019-08-13 |
| 2019-03-31 | 10.00% 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |